Key Takeaways
- Steady quarter, platform bets placed: Revenue reached INR112 crores with both rebranded segments growing, while the company capitalized two major platforms and declared a substantial interim dividend.
- EXM is the margin and momentum story: The segment grew 5.8% QoQ, expanded margins 2.6% QoQ, and its H1 sales ACV of INR17 crores already tracks to exceed last year's full-year figure.
- A single US delinquency created a contained hit: A midsized fintech client's Chapter 11 filing depressed CXM margins and PBT, but management made a 100% provision and expects no future residuary impact.
- International sales crossed a tipping point: New international sales exceeded 50% of total new sales, a trend management calls structural rather than a one-off, driven by a deliberate strategic focus.
- What to watch next quarter: The depreciation charge for newly capitalized platforms SP4 and HRMS, the pace of EXM's international expansion, and any early SaaS pilot wins for the HRMS platform.
Segment Performance & the Chapter 11 Hit
- EXM delivered on all fronts: Revenue grew 5.8% QoQ while margins rose 2.6% QoQ and 1.8% YoY, driven by a 2.4x jump in average ticket size, faster transition timelines, and cost efficiencies in payslip processing.
- CXM growth masked a one-time credit event: The segment grew 3.9% QoQ, but margins were depressed by a single US fintech client filing for Chapter 11. Adjusting for that delinquency, CXM margin would have been roughly 0.7% higher than the prior quarter.
- The provision was deliberately conservative: Management downsized deployed people immediately upon learning of the filing and chose to provide 100% on the account, so no residuary impact is expected in future quarters.
- H1 comparisons reflect the drag: H1 CXM margin came in at 12.3% versus 12.7% last year, partially impacted by the Chapter 11 delinquencies, while H1 EXM consolidated margin improved 0.8% YoY to 32.2%.
Naozer Dalal: "But still conservatively, we have made 100% provision on this account. And so therefore, there should be no residuary impact of this account in the coming or future quarters."
EXM Sales Momentum & International Pivot
- EXM sales are accelerating sharply: H1 FY24 EXM sales ACV reached INR17 crores, up roughly 40% versus H2 FY23, and management expects to exceed last year's full-year ACV of INR25 crores.
- International sales crossed the 50% threshold: New international sales now represent over half of total new sales, a trend management attributes to a deliberate strategic focus across both EXM and CXM rather than a one-off quarter.
- The international playbook is methodical: The plan for FY25 involves working with existing customers in newer geographies, building capabilities there, and then expanding to newer customers and geographies.
- Marquee wins validate the push: The company added two new logos in Q2 with ACV exceeding INR5 crores, converted targeted competitor logos, and added two new lines of business in a healthcare account won at the end of the prior financial year.
Platform Investments & the SaaS Pivot
- Two platforms moved from WIP to capitalized assets: SmartPay 4, the upgraded payroll engine, and a new HRMS platform were both capitalized as of September 30, with SP4 having completed parallel runs for a few strategic customers and the HRMS platform crossing its user acceptance testing milestone.
- SP4 migration is the near-term operational focus: Management is drawing up transition plans to migrate existing customers to SP4 over the next couple of quarters, which will determine the pace of benefits realization.
- HRMS opens a new SaaS market segment: The company will approach the market in H2 to pilot sales of the HRMS platform on a SaaS basis, with profitable client acquisition as the stated driver of the SaaS strategy.
- Depreciation impact is a known unknown: Management declined to provide guidance on the depreciation charge for the capitalized platforms, telling analysts to wait until Q3 results in January 2024 while the company evaluates useful life and market benchmarks.
Naozer Dalal: "Though I would like to state that profitable client acquisition would continue to be a key consideration and would drive our SaaS strategy."
Balance Sheet & Capital Allocation
- DSO spiked on business mix, not collection stress: DSO reached 81 days versus a typical 50-52 days, but management clarified this includes both billed and unbilled receivables. The billed component alone is roughly 51 days, and the increase reflects better international business growth.
- Working capital swelled with international scale: Segment assets in CXM increased to roughly INR60 crores from INR50 crores, segment liabilities rose 20-25%, and international business headcount jumped roughly 15% to 1,553 employees.
- A large interim dividend signals confidence: The board declared an interim dividend of INR45.7 crores, or INR30 per share, balancing internal returns, investment in newer capabilities, and work toward a sustainable dividend policy.
- M&A appetite is present but patient: Management continues to evaluate niche vertical acquisitions or geographic presence in the US across both CXM and EXM, but stated nothing concrete is on the table at the moment.
Naozer Dalal: "We will continue to evaluate niche vertical acquisitions or certain geographic presence in the US. Those are some of the strategic drivers, which we will continue to look at it."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| SP4 customer migration | Transition existing customers to upgraded SmartPay 4 payroll engine | Next couple of quarters |
| HRMS SaaS pilot | Approach market to pilot HRMS platform sales on a SaaS basis | H2 FY24 |
| EXM full-year sales | Exceed last year's full-year ACV of INR25 crores | FY24 |
| International EXM sales focus | Accelerate focus on international EXM sales, then continue into FY25 with existing customers in new geographies first | Remainder of FY24 and into FY25 |
| Chapter 11 exposure | No residuary impact from the delinquent US fintech client | All future quarters |
| Depreciation disclosure | Depreciation numbers for SP4 and HRMS platforms disclosed | Q3 FY24 results in January 2024 |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Revenue from operations | ₹112.4 cr, +19.3% YoY and +4.5% QoQ |
| CXM revenue growth | +18.3% YoY and +3.9% QoQ |
| EXM revenue growth | +21.2% YoY and +5.8% QoQ |
| International business revenue growth | +21.4% YoY and +4.6% QoQ |
| Domestic business revenue growth | +11.6% YoY and +2.1% QoQ |
| EBITDA | ₹25.4 cr, +17.4% YoY and +3.5% QoQ |
| PAT | ₹16.2 cr, +3% YoY and +2.3% QoQ |
| PBT growth | +5.3% YoY and +3.9% QoQ |
| H1 FY24 revenue | ₹220 cr, +20.6% YoY |
| H1 FY24 EBITDA | ₹50 cr, +19.3% YoY |
| H1 FY24 PAT growth | +8.4% YoY |
| H1 FY24 CXM margin | 12.3%, vs 12.7% in H1 FY23, partially impacted by Chapter 11 delinquencies |
| H1 FY24 EXM consolidated margin | 32.2%, better by 0.8% YoY |
| EXM segment margin change | +2.6% QoQ and +1.8% YoY |
| CXM margin impact from Chapter 11 delinquency | ~0.7% lower than previous quarter, adjusting for the delinquency |
| EXM Payroll business revenue growth | +22.5% YoY and +8.7% QoQ |
| EXM Compliance business revenue growth | +16.2% YoY, -4.5% QoQ |
| EXM sales ACV in H1 FY24 | ₹17 cr, up ~40% vs H2 FY23 |
| New EXM sales ticket size | ₹46 lakhs in Q2, 2.4x vs Q1 |
| Employee records processed | 0.13 cr at end of September, market leader by 20-30% over competition |
| Employee record volume growth | +12.5% YoY |
| Staff attrition | 8.1% in Q2, near best-in-class in domestic outsourcing |
| DSO (billed plus unbilled) | 81 days, flat vs Q2 FY23 and Q4 FY23 |
| Manila operational seats | Just under 1,200, up from 600 |
| Cash and liquid funds | ~₹151 cr |
| Interim dividend declared | ₹45.7 cr, ₹30 per share |